Prof Paul Maruff will present the following:
- Sensitivity of the Alzheimer Disease Cooperative Study Preclinical Alzheimer Cognitive Composite (Adcs-Pacc), to amyloid load in preclinical AD
- Refining the natural history of global and regional AΒ-Amyloidb deposition in sporadic Alzheimer’s disease
- Genetic risk profile for prediction of cognitive decline in pre-symptomatic AD clinical trials
- Disruption of cholinergic neurotransmission in preclinical Alzheimer’s disease: Novel biomarkers for early detection
- Investigating serum irisin levels in a cognitively healthy elderly cohort
- Reliability and reproducibility of cognitive composites for Alzheimer’s disease secondary prevention trials: The Power-PACC
